FDA to Release Report on Child Deaths After COVID Shots
On Sept. 4, 2025, the commissioner of the U.S. Food and Drug Administration (FDA), Marty Makary, MD, announced the agency will release a detailed report investigating deaths among children following receipt of COVID-19 shots.1 2 Dr. Makary stated that officials have begun carrying out an “intensive investigation” into reports submitted to the Vaccine Adverse Event […]
CDC’s ACIP: The Next Generation
On Sept. 15, 2025, the U.S. Department of Health and Human Services (DHHS) announced the appointment of five additional members to the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP). The new members—Catherine Stein, PhD; Evelyn Griffin, MD; Hillary Blackburn, PharmD, MBA; Kirk Milhoan; MD, PhD; and Raymond Pollak, MD—bring […]
MMR Whistleblower
The measles, mumps, rubella vaccine—MMR—is one of the most widely given vaccines in the world. It’s given to most American babies in two doses. Yet, you probably never heard about this controversy. It’s brought to us by a scientist named Stephen Krahling who worked on a project at Merck called “Protocol 7” and was uniquely […]
Origins of Medical Harm
The level of compensation doctors receive from Medicare is currently under renewed scrutiny; these standards are mirrored by health insurers. The quantity of reimbursement weighted to specialists is likely to shift towards primary care physicians. Reconfiguration of doctors’ fees is overdue, although they are determined by a secretive American Medical Association committee. Analysis and debate […]
COVID-19 Shots Associated with Neuropsychiatric Disorders
A 2025 study published in the International Journal of Innovative Research in Medical Science examined whether mRNA COVID-19 shots are linked to neuropsychiatric conditions, raising questions about their potential to damage the brain and mental health. The researchers, most of which are affiliated with The Wellness Company and the McCullough Foundation, note that the mRNA […]
FDA Suspends Chikungunya Vaccine Over Safety Concerns
The U.S. Food and Drug Administration (FDA) announced on Aug. 22, 2025 that it has suspended the license for French drugmaker Valneva’s chikungunya vaccine, warning that its continued use “poses a danger to public health” following a risk–benefit analysis conducted by the agency’s Center for Biologics Evaluation and Research (CBER). The decision came after reports […]